Work

Abstract B25: BET bromodomain inhibition targets adaptive responses to lapatinib in HER2-positive breast cancer

Year: 2016

Type: conference-abstract

Source: Molecular Cancer Research

DOI: 10.1158/1557-3125.advbc15-b25

Authors: Timothy J. Stuhlmiller, Samantha M. Miller, Jon S. Zawistowski, James S. Duncan, Steven P. Angus, Deborah A. Granger, Rachel A. Reuther, Kyla A.L. Collins, Gomez M. Shawn, Pei-Fen Kuan, Xin Chen, Noah Sciaky, Gary L. Johnson

Institution: University of North Carolina at Chapel Hill

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2537345290

Cites:

Cited by:

Related to: 10